Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Evaluation Review
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cartwright, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cartwright, W. S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Drug Abuse
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cost-Benefit and Cost-Effectiveness Analysis of Drug Abuse Treatment Services

William S. Cartwright

National Institutes of Health

The foundations of cost-benefit analysis and cost-effectiveness analysis (CB/CEA) for drug abuse treatment are developect An economic model of addict choice and drug markets is presented. This model is synthesized with the current "cost of illness" methods used to measure the burden of the disease to society. The problem of doing cost-effectiveness studies in the presence of large nonhealth benefits is examined, and guidance is offered to clinical studies with a cost-effectiveness component or to stand-alone cost-effectiveness studies. References and an extensive bibliography on drug abuse treatment-related CB/CEA studies are appended.

Evaluation Review, Vol. 22, No. 5, 609-636 (1998)
DOI: 10.1177/0193841X9802200503
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Eval RevHome page
M. T. French, M. C. Roebuck, M. L. Dennis, S. H. Godley, H. A. Liddle, and F. M. Tims
Outpatient Marijuana Treatment for Adolescents: Economic Evaluation of a Multisite Field Experiment
Eval Rev, August 1, 2003; 27(4): 421 - 459.
[Abstract] [PDF]

Home page
 Eval RevHome page
M. T. French, H. J. Salome, A. Krupski, J. R. Mckay, D. M. Donovan, A. T. Mclellan, and J. Durell
Benefit-Cost Analysis of Residential and Outpatient Addiction Treatment in the State of Washington
Eval Rev, December 1, 2000; 24(6): 609 - 634.
[Abstract] [PDF]